Literature DB >> 22031115

A missense mutation in PKD1 attenuates the severity of renal disease.

York Pei1, Zheng Lan, Kairong Wang, Miguel Garcia-Gonzalez, Ning He, Elizabeth Dicks, Patrick Parfrey, Gregory Germino, Terry Watnick.   

Abstract

Mutations of PKD1 and PKD2 account for most cases of autosomal dominant polycystic kidney disease (ADPKD). Compared with PKD2, patients with PKD1 typically have more severe renal disease. Here, we report a follow-up study of a unique multigeneration family with bilineal ADPKD (NFL10) in which a PKD1 disease haplotype and a PKD2 (L736X) mutation co-segregated with 18 and 14 affected individuals, respectively. In our updated genotype-phenotype analysis of the family, we found that PKD1-affected individuals had uniformly mild renal disease similar to the PKD2-affected individuals. By sequencing all the exons and splice junctions of PKD1, we identified two missense mutations (Y528C and R1942H) from a PKD1-affected individual. Although both variants were predicted to be damaging to the mutant protein, only Y528C co-segregated with all of the PKD1-affected individuals in NFL10. Studies in MDCK cells stably expressing wild-type and mutant forms of PKD found that cell lines expressing the Y528C variant formed cysts in culture and displayed increased rates of growth and apoptosis. Thus, Y528C functions as a hypomorphic PKD1 allele. These findings have important implications for pathogenic mechanisms and molecular diagnostics of ADPKD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22031115      PMCID: PMC4105019          DOI: 10.1038/ki.2011.370

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

Review 1.  Genetics and pathogenesis of polycystic kidney disease.

Authors:  Peter Igarashi; Stefan Somlo
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

2.  Genetic heterogeneity of polycystic kidney disease in Europe.

Authors:  D J Peters; L A Sandkuijl
Journal:  Contrib Nephrol       Date:  1992       Impact factor: 1.580

3.  Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations.

Authors:  Feng Qian; Alessandra Boletta; Anil K Bhunia; Hangxue Xu; Lijuan Liu; Ali K Ahrabi; Terry J Watnick; Fang Zhou; Gregory G Germino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

4.  Somatic inactivation of Pkd2 results in polycystic kidney disease.

Authors:  G Wu; V D'Agati; Y Cai; G Markowitz; J H Park; D M Reynolds; Y Maeda; T C Le; H Hou; R Kucherlapati; W Edelmann; S Somlo
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

5.  Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.

Authors:  Riccardo Magistroni; Ning He; Kairong Wang; Robin Andrew; Ann Johnson; Patricia Gabow; Elizabeth Dicks; Patrick Parfrey; Roser Torra; Jose L San-Millan; Eliecer Coto; Marjan Van Dijk; Martijn Breuning; Dorien Peters; Nadja Bogdanova; Giulia Ligabue; Alberto Albertazzi; Nick Hateboer; Kyproula Demetriou; Alkis Pierides; Constantinos Deltas; Peter St George-Hyslop; David Ravine; York Pei
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

6.  The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

Authors:  F Qian; T J Watnick; L F Onuchic; G G Germino
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

7.  The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease.

Authors:  Sandro Rossetti; Sarah Burton; Lana Strmecki; Gregory R Pond; Jośe L San Millán; Klaus Zerres; T Martin Barratt; Seza Ozen; Vicente E Torres; Erik J Bergstralh; Christopher G Winearls; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

8.  Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group.

Authors:  N Hateboer; M A v Dijk; N Bogdanova; E Coto; A K Saggar-Malik; J L San Millan; R Torra; M Breuning; D Ravine
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

9.  Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

Authors:  D Ravine; R N Gibson; R G Walker; L J Sheffield; P Kincaid-Smith; D M Danks
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

10.  Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells.

Authors:  A Boletta; F Qian; L F Onuchic; A K Bhunia; B Phakdeekitcharoen; K Hanaoka; W Guggino; L Monaco; G G Germino
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

View more
  30 in total

Review 1.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

2.  Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.

Authors:  Godela M Brosnahan; Kaleab Z Abebe; Charity G Moore; Frederic F Rahbari-Oskoui; Kyongtae T Bae; Jared J Grantham; Robert W Schrier; William E Braun; Arlene B Chapman; Michael F Flessner; Peter C Harris; Marie C Hogan; Ronald D Perrone; Dana C Miskulin; Theodore I Steinman; Vicente E Torres
Journal:  Am J Kidney Dis       Date:  2018-01-03       Impact factor: 8.860

3.  Type of PKD1 mutation influences renal outcome in ADPKD.

Authors:  Emilie Cornec-Le Gall; Marie-Pierre Audrézet; Jian-Min Chen; Maryvonne Hourmant; Marie-Pascale Morin; Régine Perrichot; Christophe Charasse; Bassem Whebe; Eric Renaudineau; Philippe Jousset; Marie-Paule Guillodo; Anne Grall-Jezequel; Philippe Saliou; Claude Férec; Yannick Le Meur
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

Review 4.  Autosomal dominant polycystic kidney disease in children.

Authors:  Melissa A Cadnapaphornchai
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

Review 5.  Kidney: polycystic kidney disease.

Authors:  Binu M Paul; Gregory B Vanden Heuvel
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-09-03       Impact factor: 5.814

6.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

7.  Identification of PKD1 and PKD2 gene variants in a cohort of 125 Asian Indian patients of ADPKD.

Authors:  Shewata Pandita; Vijaya Ramachandran; Prahlad Balakrishnan; Arndt Rolfs; Oliver Brandau; Sabrina Eichler; Anil Kumar Bhalla; Dinesh Khullar; Vindu Amitabh; Sivaramakrishnan Ramanarayanan; Vijay Kher; Jyotsna Verma; Sudha Kohli; Renu Saxena; Ishwar Chander Verma
Journal:  J Hum Genet       Date:  2019-02-28       Impact factor: 3.172

Review 8.  Predictors of autosomal dominant polycystic kidney disease progression.

Authors:  Robert W Schrier; Godela Brosnahan; Melissa A Cadnapaphornchai; Michel Chonchol; Keith Friend; Berenice Gitomer; Sandro Rossetti
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

Review 9.  Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.

Authors:  Emilie Cornec-Le Gall; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2017-10-16       Impact factor: 10.121

10.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.